XellSmart
PrivateLast Round
Series C
Extension
Apr 2, 2026
Total Funding Raised
$185.64M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
XellSmart operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series C Extension round in April 2026.
XellSmart is a biotechnology company that develops clinical-grade, allogeneic, off-the-shelf, iPSC-derived cell therapies for central nervous system diseases such as Parkinson's and ALS.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XellSmart Comparables
Compare XellSmart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai UniXell Biotechnology | 87% | |
| Kenai Therapeutics | 85% | |
| Nuwacell Biotechnologies Co., Ltd. | 82% |
For institutional investors. Book with your work email.
XellSmart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 2, 2026 | ||||
| Series B | Jan 14, 2026 | ||||
| Series A Extension | Apr 1, 2023 | ||||
| Series A Extension | Nov 8, 2022 | ||||
| Series A | Jan 9, 2022 | ||||
Pre Seed | Sep 8, 2021 |
For institutional investors. Book with your work email.
XellSmart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huatai Zijin Investment Co., Ltd. | Series A Extension |
| Fig | Series A Extension |
| Junshan Investment | Series A Extension |
| Oriza Holdings | Series A Extension |
| Tianjin TEDA Science and Technology Investment Co., Ltd. | Pre Seed, Angel |
| YuanBio Venture Capital | Pre Seed |
| Next Capital | Series A Extension, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 92% MoM.
- Jun 21, 2026
Monthly visitors increased 63% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 18, 2026
Xellsmart's new clinical data for off-the-shelf cell therapy XS411 are presented at the International Congress of Parkinson's Disease and Movement Disorders on Oct 18th '26.
- recognized_asAug 6, 2026
Xellsmart's XS411 cell therapy for Parkinson's disease receives Fast Track Designation from the US Food and Drug Administration in Aug '26.
For institutional investors. Book with your work email.
XellSmart Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about XellSmart's valuation, stock price, and market status.
Is XellSmart a public or private company?
XellSmart is a private company.
What is the current stock price of XellSmart?
XellSmart is a private company, so its shares have no public market price. Caplight tracks XellSmart's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is XellSmart worth (valuation)?
Valuation information for XellSmart is not publicly available.
Can I buy XellSmart stock?
XellSmart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was XellSmart's last funding round?
XellSmart's most recent funding round was Series C Extension on April 2, 2026.
Who are the main investors in XellSmart?
Key investors in XellSmart include Fig, Frees Fund, Gold Mountains Asset Management, Lilly Asia Ventures, Lilly Asia Ventures.
Will XellSmart IPO soon?
No public IPO plans have been announced for XellSmart.
How can I track XellSmart secondary market activity?
Caplight tracks bids, offers, and trades in XellSmart's shares on secondary markets.